Concepedia

Caitlyn L. Miller

CL

11

Publications

1.3K

Citations

10

H-Index

1993

Active since

Affiliations

Stanford University(Current)

Howard Hughes Medical Institute

Brigham and Women's Hospital

University of California, San Francisco

University Hospital of Basel

Caitlyn L. Miller is an author at Stanford University specializing in medicine, cancer research, and cell biology.

ORCID

Top concepts

Publications per year

1993–2023

11

Publications

11

LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation

Green Ahn, Steven M. Banik, Caitlyn L. Miller et al. · Nature Chemical Biology · 2021 · 521 citations · Full text

, , +8

Targeted glycan degradation potentiates the anticancer immune response in vivo

Melissa A. Gray, Michal A. Stanczak, Natália Rodrigues Mantuano et al. · Nature Chemical Biology · 2020 · 338 citations · Full text

, , +7

Design of a mucin-selective protease for targeted degradation of cancer-associated mucins

Kayvon Pedram, D. Judy Shon, Gabrielle S. Tender et al. · Nature Biotechnology · 2023 · 81 citations · Full text

Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma

Bianca M. Marin, Kendra A. Porath, Sonia Jain et al. · Neuro-Oncology · 2021 · 76 citations · Full text

An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA

Nishant Mehta, Sainiteesh Maddineni, Ryan L. Kelly et al. · Scientific Reports · 2020 · 66 citations · Full text

Rows per page

1–5 of 11